Randomized trial of regional plus systemic fluorinated pyrimidine compared with systemic fluorinated pyrimidine in treatment of colorectal liver metastases

European Journal of Surgical Oncology

Volumn 26, Issue 5, 2000, Pages 468-473

  Allen Mersh, T G ^a   Glover, C ^a   Fordy, C ^a   Mathur, P ^a   Quinn, H ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Chemotherapy; Colorectal liver metastases; Hepatic arterial floxuridine; Systemic fluorouracil

Indexed keywords

FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; PYRIMIDINE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; GASTRITIS; HUMAN; INTERMETHOD COMPARISON; LIVER CIRCULATION; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VOMITING;

EID: 0033834207     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.1999.0924     Document Type: Article

References (28)

1. Regional infusion chemotherapy for colorectal liver metastases - Where is it going?
2. Reappraisal of hepatic arterial infusion in the treatment of non-resectable liver metastases from colorectal cancer
3. Update of randomized study of intrahepatic vs systemic infusion of FUDR in patients with liver metastases from colorectal carcinoma
4. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomised trial
5. Quality of life and survival with continuous hepatic artery floxuridine infusion for colorectal liver metastases
6. A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2-deoxyuridine and 5 fluorouracil
7. Regional chemotherapy for hepatic metastases of colorectal cancer (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial
8. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin
9. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal carcinoma confined to the liver
10. Hepatic arterial cannulation for regional chemotherapy is safe in patients with a liver metastasis volume of less than 1 litre
11. Effect of aberrant hepatic arterial anatomy on tumour response to regional floxuridine infusion for colorectal liver metastases
12. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion
13. Pyridoxine for the palmar-plantar erythrodysesthesia syndrome
14. The sickness impact file: Development and final revision of a health status measure
15. Measuring psychological and physical distress in cancer patients; structure and application of the Rotterdam Symptom Checklist
16. The hospital anxiety and depression scale
17. Measurement of response to treatment in colorectal liver metastases
18. Assessment of response to therapy in advanced breast cancer
19. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer
20. Minimisation
21. Can the subsequent development of colorectal liver metastases be predicted?
22. Relation between tumour size, quality of life and survival in patients with colorectal liver metastases
23. Nonparametric estimations for incomplete observations
24. Statistical analysis of longitudinal quality of life data with missing values
25. Advanced colorectal cancer meta-analysis project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer evidence in terms of response rate
26. Design and analysis of randomised clinical trials requiring prolonged observations
27. Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases